Validation of criterion-based patient assignment and treatment effectiveness of a multidisciplinary modularized managed care program for headache.

The Journal of Headache and Pain
Thomas-Martin Wallasch, Christiane Hermann

Abstract

This prospective observational study evaluates the validity of an algorithm for assigning patients to a multidisciplinary modularized managed care headache treatment program. N = 545 chronic headache sufferers [migraine (53.8 %), migraine + tension type (30.1 %), tension type (8.3 %) or medication overuse headache (6.2 %), other primary headaches (1.5 %)] were assigned to one of four treatment modules differing with regard to the number and types of interventions entailed (e.g., medication, psychological intervention, physical therapy, etc.). A rather simple assignment algorithm based on headache frequency, medication use and psychiatric comorbidity was used. Patients in the different modules were compared with regard to the experienced burden of disease. 1-year follow-up outcome data are reported (N = 160). Headache frequency and analgesic consumption differed significantly among patients in the modules. Headache-related disability was highest in patients with high headache frequency with/without medication overuse or psychiatric comorbidity (modules 2/3) compared to patients with low headache frequency and medication (module 0). Physical functioning was lowest in patients with chronic headache regardless of additional problem...Continue Reading

References

Aug 1, 1992·Pain·Michael Von KorffSamuel F Dworkin
May 1, 1994·The Annals of Pharmacotherapy·J C Clouse, J T Osterhaus
Jul 17, 1998·Headache·R Smith
Jun 7, 1992·PharmacoEconomics·J T OsterhausJ R Plachetka
Apr 29, 1999·Archives of Internal Medicine·X H HuM L Berger
Sep 11, 2002·Applied Psychophysiology and Biofeedback·Donald B PenzienFrank Andrasik
Apr 12, 2003·Neurology·R B LiptonP J Goadsby
May 20, 2003·Headache·Andrew Blumenfeld, Marie Tischio
Jun 6, 2003·Headache·Eugene M CassidyVeronica O'Keane
Feb 26, 2004·Cephalalgia : an International Journal of Headache·UNKNOWN Headache Classification Subcommittee of the International Headache Society
Dec 21, 2004·Cephalalgia : an International Journal of Headache·Z KatsaravaV Limmroth
Oct 13, 2006·Headache·Steven M BaskinTodd A Smitherman
Oct 13, 2006·Headache·Morris MaizelsDonald B Penzien
Mar 27, 2007·Cephalalgia : an International Journal of Headache·Lj StovnerJ-A Zwart
Oct 31, 2007·Current Medical Research and Opinion·Julio PascualArturo López-Gil
Jan 11, 2008·Headache·Ann I ScherRichard B Lipton
Sep 17, 2008·Internal and Emergency Medicine·Fabio AntonaciTimothy J Steiner
Nov 26, 2008·Cephalalgia : an International Journal of Headache·N GhiottoG Nappi
May 29, 2009·Headache·Birgit Gunreben-StempfleKathrin Ulrich
Jul 21, 2009·Cephalalgia : an International Journal of Headache·G SancesG Nappi
Sep 22, 2010·Cephalalgia : an International Journal of Headache·Rigmor JensenJes Olesen
Jul 8, 2011·Acta Neurologica Scandinavica. Supplementum·K Hagen, L J Stovner

❮ Previous
Next ❯

Citations

Dec 29, 2015·Current Pain and Headache Reports·Tzu-Hsien Lai, Shuu-Jiun Wang
Jul 14, 2012·The Journal of Headache and Pain·Thomas-Martin Wallasch, Peter Kropp
Apr 19, 2016·International Journal of Environmental Research and Public Health·Nuno PomboIvan Chorbev
Jan 31, 2017·The Journal of Headache and Pain·Amerigo CostaRosario Iannacchero
Oct 4, 2013·The Journal of Headache and Pain·Virginie DoussetTobias Kurth

❮ Previous
Next ❯

Software Mentioned

STB
Predictive Analytics SoftWare ( PASW )
SPSS
AC

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.